A new study has shown pregnant women with obesity could reduce the health risks for their infants through improved diet and more physical activity.

Scientists (WFIRM) have developed a method to bioprint a type of cartilage that could someday help restore knee function damaged by arthritis or injury.

National Institutes of Health researchers have discovered a gene in mice that controls the craving for fatty and sugary foods and the desire to exercise.

A research team has reported that compounds simultaneously targeting Mpro and cathepsin L could improve the treatment of COVID-19 infection.

A team from the University of Sheffield has designed and built a specialist microscope and shared the build instructions to help make this equipment available worldwide.

Unrelated mutations, when present in the blood, can lead to false positive results in men with advanced prostate cancer who are undergoing liquid biopsies.

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

Researchers must consider a number of factors for in vitro experiments. Selecting the most appropriate cell line or primary culture for the project at hand is only the first step. Researchers must then be vigilant to prevent contaminating the culture, from the initial moments it is plated and all throughout consecutive passages.

To learn more about the PANDIS model, its aims, and how it can be used to help diagnose and treat patients suffering from a range of conditions spanning from cancers to “mystery chronic diseases”, Technology Networks spoke with PANDIS’s founders, Professor Gilles Guillemin and Catherine Stace.

An ambitious new research project powered by hitherto inaccessible techniques is investigating whether a crowded cellular environment might have a role to play in the origin of neurodegeneration.

In a recent preprint study, a team of researchers from Gladstone Institutes discovered new insights into how SARS-CoV-2 causes heart damage. To learn more about the findings and their implications for the monitoring and treatment of COVID-19 patients, we spoke to Bruce Conklin, MD, senior investigator at Gladstone Institutes.

To meet the diverse and growing needs across biopharmaceutical R&D, a wide range of analytical tools continue to evolve. In this article, we explore the current trends and driving forces in biopharmaceutical analysis.